Document is current
Any future updates will be listed below
-
Authors
Nomura, Yoko
Aoki, Shuichiro
Kitamoto, Kohdai
Ueda, Kohei
Azuma, Keiko
Inoue, Tatsuya
Obata, Ryo https://orcid.org/0000-0002-1762-0797
-
Funding
Funding for this research was provided by:
Foundation for Promotion of Material Science and Technology of Japan (JP19K18836)
- License Information
-
More Information
Article History
Received: 4 October 2023
Revised: 19 April 2024
Accepted: 28 April 2024
First Online: 9 May 2024
Declarations
: This study was approved by the research ethics committee of the Graduate School of Medicine and Faculty of Medicine at the University of Tokyo (#2217).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the the Graduate School of Medicine and Faculty of Medicine at the University of Tokyo and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was given for patient information to be stored in the hospital database and used for research. Otherwise, based on the regulations of the Japanese Guidelines for Epidemiologic Study 2021, the study protocols did not require that each patient provide written informed consent. Instead, the protocol was posted at the outpatient clinic and/or website of the department to notify study participants.
: Ryo Obata received honoraria for speaking/consulting from Santen, Bayer, Novartis, Chugai, Senju and Boehringer Ingelheim.
